Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Hydreight Technologies Inc ( (TSE:NURS) ) has shared an update.
Hydreight Technologies Inc. has successfully closed an oversubscribed $11.5 million convertible debenture offering, including the full exercise of an over-allotment option. This funding will support the company’s growth strategy and long-term goals, as it has recently achieved profitability. The offering was led by Canaccord Genuity Corp. and involved a syndicate of agents. The proceeds are intended for general corporate and working capital purposes, with the offering subject to final approval by the TSX Venture Exchange.
The most recent analyst rating on (TSE:NURS) stock is a Buy with a C$8.50 price target. To see the full list of analyst forecasts on Hydreight Technologies Inc stock, see the TSE:NURS Stock Forecast page.
More about Hydreight Technologies Inc
Hydreight Technologies Inc. is a leader in digital healthcare solutions, focusing on building one of the largest mobile clinic networks in the United States. The company offers a proprietary, fully integrated platform to support its services.
Average Trading Volume: 344,259
Technical Sentiment Signal: Buy
Current Market Cap: C$87.82M
Find detailed analytics on NURS stock on TipRanks’ Stock Analysis page.
Trending Articles:
- Daniel Ives Lifts Palantir (PLTR) to New Street-High Price Target, Stock Hits a Fresh 52-Week High
- “Boeing Has Backed Itself Into a Corner,” Says Union, Boeing Stock (NYSE:BA) Gains Anyway
- “You Received a Refund Within 24 Hours”: Elon Musk Claps Back on Sam Altman’s Refund Request, Tesla Stock (NASDAQ:TSLA) Surges